Liquid Dosage
Oncology
As a result of growing competition and more stringent regulatory requirements for end-user safety, improving the convenience and ease of administration of parenteral therapeutics is becoming a common strategy for biotechnology and pharmaceutical companies. Manufacturers wishing to gain market share and provide high quality products for healthcare professionals and cancer patients alike are increasingly investing in the development and delivery of liquid dosage forms, freeze-dried products and injectables.
Pharmaceutical Development
GEA is known all over the world for its individual and tailor-made process plant for the manufacture of free-flowing pharmaceutical and biotechnology products. Complete plant, modular equipment, process units and skids can be assembled, tested and qualified in our own production facilities. We perform tests and trial runs with appropriate media to demonstrate the functionality of all components and equipment before the plant is delivered.
In collaboration and partnership with our customers, we aim to develop and deliver high-performance plant and economic process systems that comply with the highest operational safety and environmental standards; we want our customers to use our groundbreaking solutions to manufacture even better products in the future.
GEA can supply a specialized, contained and fully integrated system when no standard off-the-shelf one exists, particularly for toxic or highly potent drugs such as cytostatics or echo contrast media. With our innovative ideas and fresh approaches, together with your project team, we will find a solution that’s tailored to your needs — from basic engineering to fabrication and qualification.
المنتجات والتقنيات
يتم عرض 4 من 8
Hygienic pumps
GEA Hilge offers a versatile range of centrifugal and positive displacement pumps for a wide variety of sensitive applications in the beverage, food and pharmaceutical industries.
Lyophilizers (Pharma Freeze Dryers)
GEA's thorough understanding of the lyophilization process enables them to supply a comprehensive range of products and services, comprising laboratory equipment, pilot plants for research and small-scale production batches, industrial size pharmaceutical production freeze dryers.
R&D Drying Systems
GEA's versatile range of R&D drying & particle processing equipment - for advanced powder processing within food and dairy products, chemicals and pharmaceuticals.
أنظمة التحميل/التفريغ
يُعد التصميم والتطوير وإنتاج نظم التحميل والتفريغ للاستخدامات في العديد من الصناعات هو الأختصاص الأساسي لمجموعة GEA. ومهما كان المنتج أو العملية، فإن الحلول القياسية أو المصممة حسب الحاجة، سواء كانت تعمل يدويًا أو مؤتمتة بالكامل، يمكن بناؤها وتسليمها لتلبية الاحتياجات الفردية لعملائنا.
Downloads
رؤى GEA
GEA reports profitable growth for 2025 and expects accelerated revenue growth
GEA’s past fiscal year was one of significant growth and further profitability gains. In particular, the technology group substantially increased order intake, with all divisions contributing here. GEA also made progress in all Mission 30 strategic growth areas. In addition, GEA met key interim targets under its climate plan ahead of schedule. Major milestones in fiscal year 2025 were admission to the DAX index, the award of one of the largest contracts in the company’s history, and streamlining of the corporate structure.
كيف يعيد SmartParc كتابة قواعد إنتاج الأغذية
بفضل موقع تصنيع SmartParc الجديد، تعمل شركات تجهيز الأغذية في المملكة المتحدة على خفض تكاليف التشغيل والانبعاثات. ومع وجود تقنية التسخين والتبريد من GEA في جوهرها، يوضح نموذج الإنتاج التعاوني هذا كيف يعمل الابتكار على تسريع طموحات قطاع الصناعة للوصول إلى صافي انبعاثات صفري.
مركز اختبار علوم الأغذية
"تخمير البيض مثل تخمير الجعة." هذا نوع المقارنات التي تجعلك تبتسم - ومن ثم تضيء الفكرة في عقلك: شيء معقد يبدو بسيطاً فجأة. خلال هذا الفيلم الشخصي، الذي تدور أحداثه في قلب الأراضي الزراعية في الولايات المتحدة، نستكشف التخمير الدقيق والعمل الواقعي الذي يتطلبه تحويل الفكرة إلى الأغذية.
